Trials / Completed
CompletedNCT02827383
Pilot Stair Climbing Study
Pilot Study to Test the Effect of Fractionalized Vigorous-Intensity Activity on Acute Glucose in Adults at Risk for Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Jennifer Gay · Academic / Other
- Sex
- All
- Age
- 40 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study seeks to demonstrate feasibility to conduct data collection and illustrate potential for effect of fractionalized bouts of stair climbing on glucose control in adults at risk for type 2 diabetes.
Detailed description
Objective: Compare the short-term effects of two different fractionalized stair climbing bout protocols on glucose control among adults at risk for type 2 diabetes. Rationale: Fractionalized physical activity is associated with reduced BMI, glycated hemoglobin, lower 2-hr plasma glucose and insulin sensitivity in cross-sectional studies. Yet, few studies have examined the effects of fractionalized or intermittent physical activity in a prospective manner. Furthermore, the research is limited to patients with diagnosed type 2 diabetes, or using exercise of a moderate intensity. The hypothesis is that stair climbing, a vigorous-intensity activity, may have a greater health effect. However, this has not been tested in short bouts of activity that are spread out during a day. Implications: Fractionalized physical activity may be more feasible for adults at risk for, or with diagnosed type 2 diabetes who are not currently active. These short bouts can increase energy expenditure throughout the day, rather than in one long continuous bout as currently recommended.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Stair Climbing Frequency | Includes 1 sedentary day prior to completing crossover phases. |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-07-11
- Last updated
- 2016-10-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02827383. Inclusion in this directory is not an endorsement.